HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Kim A Papp Selected Research

efalizumab

1/2008Safety of efalizumab therapy in patients with moderate to severe psoriasis: an open-label extension of a phase IIIb trial.
3/2007Efalizumab for the treatment of psoriatic arthritis.
6/2006The long-term efficacy and safety of new biological therapies for psoriasis.
5/2006Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: a phase IIIb, randomized, controlled trial.
4/2006Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis.
4/2006Long-term management of plaque psoriasis with continuous efalizumab therapy.
1/2006A favourable benefit/risk ratio with efalizumab: a review of the clinical evidence.
1/2006Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis.
1/2006Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches.
1/2006Evaluation of efalizumab using safe psoriasis control.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Kim A Papp Research Topics

Disease

40Psoriasis (Pustulosis Palmaris et Plantaris)
09/2015 - 12/2002
9Infection
09/2015 - 12/2005
3Skin Neoplasms (Skin Cancer)
09/2015 - 02/2012
3Psoriatic Arthritis
10/2012 - 10/2004
3Atopic Dermatitis (Atopic Eczema)
01/2006 - 02/2005
2Pruritus (Itching)
01/2013 - 12/2003
2Cardiovascular Diseases (Cardiovascular Disease)
10/2012 - 04/2012
2Inflammation
04/2012 - 01/2006
2Latent Tuberculosis
07/2011 - 06/2007
1Melanoma (Melanoma, Malignant)
09/2015
1Pain (Aches)
01/2013
1Overweight
10/2012
1Seborrheic Dermatitis
07/2012
1Atherosclerosis
04/2012
1Stroke (Strokes)
03/2012
1Myocardial Infarction
03/2012
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2012
1Neoplasms (Cancer)
10/2011
1Body Weight (Weight, Body)
10/2010
1Carcinoma (Carcinomatosis)
01/2008
1Multiple Sclerosis
06/2007
1Lymphoma (Lymphomas)
06/2007
1Joint Diseases (Joint Disease)
03/2007
1Kaposi Varicelliform Eruption (Eczema Herpeticum)
01/2006
1Tetanus
02/2005
1Rubella (German Measles)
02/2005
1Measles
02/2005
1Diphtheria
02/2005
1Ankylosing Spondylitis
10/2004
1Rheumatoid Arthritis
10/2004
1Juvenile Rheumatoid Arthritis (Juvenile Idiopathic Arthritis)
10/2004
1Chills
12/2002

Drug/Important Bio-Agent (IBA)

17efalizumabFDA Link
01/2008 - 12/2003
8TNFR-Fc fusion protein (etanercept)FDA Link
08/2012 - 10/2004
7monoclonal antibody CNTO 1275 (CNTO 1275)FDA Link
05/2012 - 05/2008
4adalimumab (Humira)FDA Link
09/2015 - 01/2011
4InterleukinsIBA
07/2015 - 05/2008
4Interleukin-12 (IL 12)IBA
05/2012 - 05/2008
4Immunoglobulin G (IgG)IBA
05/2006 - 11/2004
3alefacept (Amevive)FDA Link
05/2012 - 12/2002
3infliximab (Remicade)FDA Link
05/2012 - 01/2006
3Methotrexate (Mexate)FDA LinkGeneric
10/2011 - 03/2007
3pimecrolimus (Elidel)FDA Link
01/2006 - 02/2005
2AntibodiesIBA
07/2015 - 02/2005
2Phosphotransferases (Kinase)IBA
01/2015 - 03/2014
2CalcineurinIBA
07/2012 - 01/2006
2CytokinesIBA
04/2012 - 05/2008
2briakinumabIBA
02/2012 - 10/2011
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2011 - 06/2007
1EsapentIBA
09/2015
1Interleukin-17 (Interleukin 27)IBA
07/2015
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
01/2013
1apremilastIBA
01/2013
1Tacrolimus (Prograf)FDA LinkGeneric
07/2012
1Hydrocortisone (Cortisol)FDA LinkGeneric
07/2012
1Interleukin-23 (Interleukin 23)IBA
05/2012
1Carbon MonoxideIBA
04/2012
1omega-Chloroacetophenone (Mace)IBA
03/2012
1Prostaglandins A (PGA)IBA
02/2012
1AntigensIBA
06/2007
1Therapeutic UsesIBA
06/2007
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
10/2004
1betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric
01/2003
1calcipotriene (calcipotriol)FDA LinkGeneric
01/2003

Therapy/Procedure

4Phototherapy (Light Therapy)
10/2012 - 01/2006
3Biological Therapy
05/2012 - 01/2006
1Retreatment
04/2006
1Withholding Treatment
01/2006
1Therapeutics
01/2006